CLEVELAND, June 11, 2014 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced the appointment of CFO Jennifer Mabe to the Texas Society of CPAs (TSCPA) Board of Directors.
"I am honored to be recognized by the Texas Society of CPAs," said Jennifer Mabe, CFO, DATATRAK. "The organization has had a profound impact on the careers of many Accounting professionals in Texas, including me. There are many opportunities for members to advance their development and vocation through this state-wide network of dedicated leaders. I am proud to be joining the illustrious team of professionals serving on the Board."
Ms. Mabe is the CFO at DATATRAK, responsible for leading the Company's finance, investor relations, and human resource functions. Ms. Mabe has over 20 years accounting and finance experience with 14 years in the life science industry. She previously held positions at DATATRAK including Vice President of Finance as well as International Director of Quality Assurance. Ms. Mabe has held her CPA designation since 1998 and also holds the CGMA (Chartered Global Management Accountant) designation.
TSCPA exists to support its members in their professional endeavors and to promote the value and high standards of Texas CPAs. To find out more about TSCPA, visit them online at https://www.tscpa.org.
DATATRAK is located in Bryan, TX, Cleveland, OH, Cary (RTP), NC, Chicago, IL, and the UK. DATATRAK is a global company providing eClinical solutions and services to the clinical trials industry around the world. To find out more about DATATRAK, visit www.datatrak.com.
Join DATATRAK Thought Leaders:
Tweet: DATATRAK CFO named to @TXCPAs Board of Directors http://bit.ly/1l6tove
About DATATRAK International, Inc.
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAKONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina, and the UK. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on May 14, 2014 announcing its results for the first quarter period ending March 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.